Hi psi81,Reading the O&G press of late, I note that Santos recently announced a new strategy with news about a drop in output of about 10% in 2023.
They also predicted declining production in 2023, whilst increasing their spend on new gas and oil developments along with carbon capture and storage.
The stated new corporate purpose for Santos is to provide cleaner energy that is both affordable and sustainable and to help create a better world for everyone. That all sounds great but ………..
They say they have restructured their business into two divisions, 1. Upstream Gas and Liquids & 2. Santos Energy Solutions. The plan being to build a transition business which includes decarbonisation and a carbon management services business.
Perhaps this new philosophy from Santos will help CTP more actively pursue our Amadeus sub-salt opportunities in 2023 and see Dukas, Mt Kitty & Mahler turn desert sand into gold.
Also from reading the latest CTP quarterly activities report, our CEO states that Santos is advancing threeexploration wells, with drilling anticipated to start sometime in 2023, targeting hydrocarbons, helium and naturally occurring hydrogen.
Leon D. states that these wells are important to us as they give us the opportunity to leverage our strengths in natural gas to aid Australia’s energy transition, as well as providing much needed building blocks for a future business in helium and naturally-occurring hydrogen production.
Leon’s above statement could almosthave come from the new book of doctrine, according to Santos. Just this onceSantos may be about to help CTP rather than hinder us as has so often been thecase.
- Forums
- ASX - By Stock
- CTP
- Ann: Notice of Annual General Meeting/Voting Form
CTP
central petroleum limited
Add to My Watchlist
1.85%
!
5.5¢

Ann: Notice of Annual General Meeting/Voting Form, page-34
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $40.98M |
Open | High | Low | Value | Volume |
5.4¢ | 5.5¢ | 5.4¢ | $91.62K | 1.696M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 449381 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 6030 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 449381 | 0.054 |
1 | 100000 | 0.053 |
3 | 719000 | 0.052 |
1 | 800000 | 0.051 |
2 | 39000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 6030 | 1 |
0.059 | 379120 | 4 |
0.060 | 160000 | 3 |
0.061 | 100000 | 1 |
0.067 | 149268 | 1 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
CTP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online